Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation.
NCT ID: NCT01928238
Last Updated: 2015-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2012-08-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conventional vs Neurally Adjusted Ventilatory Assist in Difficult Weaning From Mechanical Ventilation
NCT02382861
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
NCT02056093
Mechanical Ventilation With Neurally-Adjusted Ventilatory Assist in Patients With ARDS
NCT01519258
NAVASET: Nava Level Titration Using Comfort Scales
NCT02133443
Neurally Adjusted Ventilatory Assist for Non Invasive Ventilation and Patient-ventilator Interaction
NCT01074866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Patients will have two 20-minute noninvasive periods :
Noninvasive neurally adjusted ventilatory assist (NIV-NAVA) and then Noninvasive pressure support ventilation (NPSV)
Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).
Noninvasive pressure support ventilation (NPSV)
Arm 2
Patients will have two 20-minute noninvasive periods :
Noninvasive pressure support ventilation (NPSV) and then Noninvasive neurally adjusted ventilatory assist (NIV-NAVA)
Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).
Noninvasive pressure support ventilation (NPSV)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).
Noninvasive pressure support ventilation (NPSV)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who tolerated a 120-min spontaneous breathing trial after recovery from their acute disease with no signs of respiratory failure
* Patients at high risk for respiratory after extubation were enrolled if they had at least two of the following risk factors for respiratory failure after extubation:
* age older than 65 years
* Chronic obstructive pulmonary disease,
* heart failure as the cause for intubation
* An Acute Physiology and Chronic Health Evaluation (APACHE)-II score greater than 12 on the day of extubation.
Exclusion Criteria
* Head trauma or surgery
* Recent gastric or oesophageal surgery
* Active upper gastrointestinal bleeding
* Excessive amount of respiratory secretions
* Poor cooperation
* Decision to limit life-supporting treatments in the ICU
* Tracheostomy or other upper airway disorders
* Lack of collaboration
* Do not resuscitate order or any decision to limit therapeutic effort in the ICU.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric VARGAS, MD-PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2011/27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.